LENALIDOMIDE | A209348 | DR REDDYS LABORATORIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. et al 5 patentsANDA 209348lenalidomide | D.N.J. | 2018-04-12 | Terminated 2020-09-17 | — |
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. et al 3 patentsANDA 209348lenalidomide | D.N.J. | 2017-07-20 | Terminated 2020-09-17 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Holland & Knight, LLP - Citizen Petition FDA-2011-P-0801 · 3 docket documents Holland & Knight LLP filed this citizen petition on behalf of research material manufacturers and distributors requesting that the FDA clarify whether Risk Evaluation and Mitigation Strategies (REMS) programs apply to non-clinical research materials, specifically lenalidomide powder sold for researc | Other | 2011-11-08 | Withdrawn | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.